(Q40249394)

18 September 2017

title

Microbiota Promotes Chronic Pulmonary Inflammation by Enhancing IL-17A and Autoantibodies (English)

1 reference

18 September 2017

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26630356%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Koshika Yadava

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26630356%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Céline Pattaroni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26630356%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

4

Aurélien Trompette

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26630356%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

5

Eva S Gollwitzer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26630356%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Anke K Sichelstiel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26630356%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Olawale Salami

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26630356%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Christophe von Garnier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26630356%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Benjamin J Marsland

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26630356%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

English

0 references

publication date

2 December 2015

1 reference

American Journal of Respiratory and Critical Care Medicine

18 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26630356%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26630356%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26630356%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

975-987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26630356%20AND%20SRC:MED&resulttype=core&format=json

Facing a "slow-motion disaster"--the UN meeting on noncommunicable diseases

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Global burden of COPD: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

The natural history of chronic airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Morphological and cellular basis for airflow limitation in smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Pathogenesis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Mediators of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

The lung tissue microbiome in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Significance of the microbiome in obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Analysis of the lung microbiome in the "healthy" smoker and in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Disordered microbial communities in asthmatic airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

The microbiome and the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

The role of the microbiome in exacerbations of chronic lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Respiratory microbiota: addressing clinical questions, informing clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Hypothesis: does COPD have an autoimmune component?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Lymphoid follicles in (very) severe COPD: beneficial or harmful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Lymphoid neogenesis in chronic inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Cigarette smoke-induced emphysema: A role for the B cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Autoantibodies in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Antielastin autoimmunity in tobacco smoking-induced emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORgamma t and LTi cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Elastase- and LPS-exposed mice display altered responses to rhinovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

QIIME allows analysis of high-throughput community sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Search and clustering orders of magnitude faster than BLAST

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Nippostrongylus brasiliensis infection leads to the development of emphysema associated with the induction of alternatively activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Chryseobacterium respiratory tract infections in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

T cell depletion protects against alveolar destruction due to chronic cigarette smoke exposure in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

IL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Functional characterization of T cell populations in a mouse model of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Serum amyloid A promotes lung neutrophilia by increasing IL-17A levels in the mucosa and γδ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

The airway microbiome and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Compartmentalized control of skin immunity by resident commensals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Application of a neutral community model to assess structuring of the human lung microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Microbiota-induced IL-1β, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Lymphoid follicles in chronic lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Role of B Cell-Activating Factor in Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

"B" for Bad, Beneficial, or Both? Lung Lymphoid Neogenesis in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Differential switching to IgG and IgA in active smoking COPD patients and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201504-0779OC

10.1164/RCCM.201504-0779OC

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26630356%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference